Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v4-FR
Language French French
Date Updated 2017-11-16 2017-11-06
Drug Identification Number 02209721 02209721
Brand name HEPARIN SODIUM 25000UNITS IN 5% DEXTROSE INJ HEPARIN SODIUM 25000UNITS IN 5% DEXTROSE INJ
Common or Proper name Heparin Sodium in Dextrose Heparin Sodium in Dextrose
Company Name B. BRAUN MEDICAL INC B. BRAUN MEDICAL INC
Ingredients DEXTROSE HEPARIN SODIUM DEXTROSE HEPARIN SODIUM
Strength(s) 5G 10000UNIT 5G 10000UNIT
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 250mL 250mL
ATC code B01AB B01AB
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2017-11-03 2017-11-03
Estimated end date Unknown Unknown
Actual end date 2017-11-15
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments